MICHELLE MULLINS: Open Payments
NPI 1548893605 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 17 payments from 7 companies in 2025. Trend: 2023 $841 · 2024 $534 · 2025 $368
Food & beverage: $288Education: $80
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $98 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $93 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| UCB, Inc. | 1 | $24 |
| GE HEALTHCARE | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: LifeVest, OPSUMIT, CAMZYOS, ELIQUIS, Briviact, VERQUVO, REPATHA, UPTRAVI.
Industry payments across MS — which companies pay providers there.
